Bowei Medical was founded at the end of 2015, and its founder, Jin Ocean, attended Harbin Institute of Technology for his PhD and conducted post-doctoral research at the University of Hamburg in Germany. The team has about 60 people, with R&D staff accounting for more than one-third, and the company is located in Shenzhen. Prior to starting his own business, Dr. Jin had been engaged in medical robotics for a long time, and in 2015, he chose to start his own business in the field of drug dispensing robotics.
In the hospital, the traditional drug dispensing, mainly divided into two ways, one is decentralized dispensing, commonly in the outpatient or inpatient departments, by the nurses for the deployment; the other is in the intravenous drug dispensing center, by the pharmacist of the hospital's intravenous drugs for unified management and deployment. The pain points of the industry are: human-medicine contact, drug spattering and other easy occupational injuries; quality control difficulties, dissolution rate, mixing accuracy, etc. by the nurse's experience, technology, fatigue and other factors affecting the obvious, poor consistency of the quality of drug dispensing; low degree of intelligence, the existing equipment interfaces are complicated, can not be interconnected, the intermediate process lack of accurate monitoring, can not be the whole process of automated supervision, the process of manual supervision of the medication process is prone to errors and The company's products and services have been widely recognized by the public and the public.
Aiming at the direction of intelligent intravenous drug dispensing, in the past few years, BWM has launched four product lines: various types of dispensing robots, automatic sorting/packaging equipment, intelligent logistics and cleaning, and static dispensing management software system. Among them, the most core product of Boway Medical is the dispensing robot. At present, the company has three products: integrated automatic dispensing robot, desktop ampoule dispensing robot, and desktop cillin dispensing robot. The advantage of the company's comprehensive automatic dispensing robot is that it not only supports the mixed prescription of Cillin/ampoule, comes with purification system, and gives full consideration to the convenience of hospitals using the layout, adopts a highly integrated design scheme, so that its footprint is also only 1/3-1/4 of the similar products; desktop ampoule dispensing robot can achieve 2s/bottle opening speed.
"After the doctor's prescription arrives at the vein center, it can be taken over by us comprehensively", said Jin Ocean, from the drug labeling, sorting, blending, and then sorting to the distribution of each department, through the hardware equipment and software system of Boway Medical to monitor the entire implementation process, which can realize the whole process of intelligent and The whole process can be realized by intelligentization and informatization.
The company's products are mainly used in static dispensing centers (PIVAS), chemotherapy dispensing rooms, hospital departments, pharmacies and consumable warehouses and other scenarios, to meet the needs of hospitals to reduce occupational injuries, improve the quality of drug dispensing, and standardize the process of dispensing drugs. The company's commercialization method is also mainly sold into hospitals through bidding and purchasing.
According to Jin Ocean, the company's commercialization model is divided into two kinds: one is hardware and software product sales, according to the specific needs of the clinic to provide a comprehensive and professional products, pricing in the hundreds of thousands to millions of dollars ranging from the other category is the wisdom of the overall solution of intravenous drug dispensing, the customer unit price of about ten million yuan. At present, the company's products have entered about 60 hospitals across the country, including nearly 50 tertiary hospitals, hundreds of machines and software systems in clinical applications.
China's intravenous dispensing industry market potential scale is huge, a three hospitals average daily intravenous drug volume in 6000 bags to 10,000 bags ranging from China's annual intravenous drug volume in tens of billions of bags or more, the next 3-5 years of intelligent static dispensing market penetration rate growth of nearly 10 times, the overall market size of hundreds of billions of yuan level. At the competitive level, there are NASDAQ-listed Omnicell overseas, and domestic manufacturers such as Weibang and Sanggu have made layouts in this field.